Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]      
Revenues $ 1,145,438 $ 959,891 $ 403,289
Operating expenses:      
Salaries and benefits 357,175 261,685 101,976
Supplies 269,239 242,083 94,224
Professional and medical fees 81,185 66,583 18,028
Lease expense 52,147 44,848 19,389
Other operating expenses 61,450 54,127 20,561
Cost of revenues 821,196 669,326 254,178
General and administrative expenses (includes contingent acquisition compensation expense of $5,092 for the year ended December 31, 2016) 60,246 55,992 31,452
Depreciation and amortization 39,551 34,545 15,061
Provision for doubtful accounts 24,212 23,578 9,509
Income from equity investments (4,764) (3,777) (1,264)
Loss (gain) on disposal or impairment of long-lived assets, net 2,355 (2,097) 1,804
Loss on debt refinancing 11,876 16,102 23,414
Merger transaction and integration costs 8,738 17,920 21,690
Gain on litigation settlement (14,101) 0 0
Termination of management agreement and IPO costs 0 5,834 0
Electronic health records incentive income (408) (1,761) (3,356)
Other expenses (income) 55 (525) (6)
Total operating expenses 948,956 815,137 352,482
Operating income 196,482 144,754 50,807
Tax receivable agreement expense (3,733) (119,911) 0
Interest expense, net (100,571) (100,980) (62,101)
Income (loss) before income taxes 92,178 (76,137) (11,294)
Income tax expense (benefit) 7,095 (148,982) 15,758
Net income (loss) 85,083 72,845 (27,052)
Less: Net income attributable to non-controlling interests (75,630) (71,416) (38,845)
Net income (loss) attributable to Surgery Partners, Inc. $ 9,453 $ 1,429 $ (65,897)
Net income (loss) per share attributable to common stockholders      
Basic (in USD per share) $ 0.20 $ 0.04 $ (2.04)
Diluted (in USD per share) [1] $ 0.20 $ 0.04 $ (2.04)
Weighted average common shares outstanding      
Basic (in shares) 48,018,944 36,066,233 32,295,364
Diluted (in shares) [1],[2] 48,190,738 37,464,387 32,295,364
[1] The impact of potentially dilutive securities for the year ended December 31, 2014 was not considered because the effect would be anti-dilutive for the period.
[2] Effect of the Reorganization in 2015, as defined in Note 1, has been retrospectively applied to all periods presented.